Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer.

Publication Year: 2024

DOI:
10.1007/s00535-023-02072-w

PMCID:
PMC10904523

PMID:
38261000

Journal Information

Full Title: J Gastroenterol

Abbreviation: J Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestKazufumi Honda and Kengo Nagashima are advisers to Toray Industries, Inc. Kazufumi Honda, Giman Jung, and Michimoto Kobayashi are inventors with patent filings for apoA2-i. None of the other authors have any conflicts of interest to declare. Conflict of interest Kazufumi Honda and Kengo Nagashima are advisers to Toray Industries, Inc. Kazufumi Honda, Giman Jung, and Michimoto Kobayashi are inventors with patent filings for apoA2-i. None of the other authors have any conflicts of interest to declare."

Evidence found in paper:

"Funding The present study was supported by funding from Toray Industries, Inc. and grants from the Japan Agency for Medical Research and Development (AMED): AMED P-CREATE [No. 21cm0106403h0006], AMED P-PROMOTE [No. 22ama221401h0001], and AMED Practical Research for Innovative Cancer Control [Nos. 19ck0106280h0003, 22ck0106661h0002]."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025